Spartans Crypto Casino Surpasses Stake and Bet365 with Revolutionary 33% CashRake and 3% Instant Cash Rewards

Alumis (ALMS) stock has seen strong multi-month share price momentum, with a 46% gain over the past month and a 361.9% total shareholder return over the past year. The stock trades at a low value score of 1, has reported a net loss of $245.153 million, and is trading at a discount of about 42% to analyst targets. Its price-to-book ratio of 8.5x is considered rich compared to the wider US Pharmaceuticals industry.